Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea.
Aged
COVID-19
/ epidemiology
Comorbidity
Continuous Positive Airway Pressure
/ methods
Cross-Sectional Studies
Female
France
/ epidemiology
Humans
Incidence
Male
Middle Aged
Pandemics
Polysomnography
Retrospective Studies
Sleep Apnea Syndromes
/ epidemiology
Treatment Adherence and Compliance
Treatment Outcome
And adherence
COVID 19
CPAP
Sleep Apnea
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
04 Mar 2022
04 Mar 2022
Historique:
received:
16
08
2021
accepted:
22
02
2022
entrez:
5
3
2022
pubmed:
6
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Whether the COVID-19 pandemic impacts Positive Airway Pressure (PAP) adherence over the long-term is unknown and only preliminary short-term data have been reported. With the aim of describing the impact of the first and second waves of COVID-19 on PAP adherence during 2020 in France, we designed a cross-sectional study of Sleep-Apnea (SA)-patients under PAP telemonitoring. To examine PAP adherence in adult SA patients, we assessed de-identified data from a non-profit healthcare provider database during the period January 1, 2019 to December 31, 2020. Included patients met the following criteria: (i) PAP-treated for at least 4 months before January 1, 2019 and with continuous PAP during both 2019 and 2020; (ii) ≥ 360 daily PAP telemonitored data per year. For PAP adherence, data were collected using the PAP-software. 8477/10482 patients were finally included in the analysis [72.4% male, median age 70 years (IQ During the first and second lockdowns, the COVID-19 pandemic had a clinically irrelevant effect on PAP adherence for the study population. Future studies are needed to describe COVID-19 pandemic impact on PAP adherence not only for long-term PAP-treated SA patients but also for incident cases. Trial registration The COVADENE study was registered on March 1st, 2021 on ClinicalTrials.gov (Identifier: NCT04775966).
Sections du résumé
BACKGROUND
BACKGROUND
Whether the COVID-19 pandemic impacts Positive Airway Pressure (PAP) adherence over the long-term is unknown and only preliminary short-term data have been reported.
METHODS
METHODS
With the aim of describing the impact of the first and second waves of COVID-19 on PAP adherence during 2020 in France, we designed a cross-sectional study of Sleep-Apnea (SA)-patients under PAP telemonitoring. To examine PAP adherence in adult SA patients, we assessed de-identified data from a non-profit healthcare provider database during the period January 1, 2019 to December 31, 2020. Included patients met the following criteria: (i) PAP-treated for at least 4 months before January 1, 2019 and with continuous PAP during both 2019 and 2020; (ii) ≥ 360 daily PAP telemonitored data per year. For PAP adherence, data were collected using the PAP-software.
RESULTS
RESULTS
8477/10482 patients were finally included in the analysis [72.4% male, median age 70 years (IQ
CONCLUSION
CONCLUSIONS
During the first and second lockdowns, the COVID-19 pandemic had a clinically irrelevant effect on PAP adherence for the study population. Future studies are needed to describe COVID-19 pandemic impact on PAP adherence not only for long-term PAP-treated SA patients but also for incident cases. Trial registration The COVADENE study was registered on March 1st, 2021 on ClinicalTrials.gov (Identifier: NCT04775966).
Identifiants
pubmed: 35246109
doi: 10.1186/s12931-022-01969-z
pii: 10.1186/s12931-022-01969-z
pmc: PMC8894547
doi:
Banques de données
ClinicalTrials.gov
['NCT04775966']
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
46Informations de copyright
© 2022. The Author(s).
Références
Thorax. 2020 May;75(5):367
pubmed: 32273335
Chronobiol Int. 2020 Aug;37(8):1181-1190
pubmed: 32757673
Sleep. 2007 Jun;30(6):711-9
pubmed: 17580592
Sleep Med. 2021 Aug;84:98-106
pubmed: 34144451
J Sleep Res. 2021 Oct;30(5):e13368
pubmed: 33955081
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32430426
J Clin Sleep Med. 2020 Nov 15;16(11):1917-1920
pubmed: 32780011
Sleep. 2021 Feb 12;44(2):
pubmed: 32918076
Am J Respir Crit Care Med. 2020 Jun 15;201(12):P28-P29
pubmed: 32281886
JAMA. 2017 Jul 11;318(2):156-166
pubmed: 28697252
Arch Bronconeumol (Engl Ed). 2020 Dec;56(12):818-819
pubmed: 32773300
Thorax. 2020 May;75(5):368
pubmed: 32273336
J Clin Sleep Med. 2019 Feb 15;15(2):301-334
pubmed: 30736888
Sleep Med. 2021 Apr;80:126-133
pubmed: 33596526
Eur J Public Health. 2021 Feb 1;31(1):23-30
pubmed: 33169169
Eur Respir J. 2021 Mar 4;57(3):
pubmed: 33214202